Boston Scientific (BSX) Tops Q4 EPS by 4c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $43.05 -1.96%
EPS Growth %: +5.3%
Financial Fact:
Income tax expense: 29M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +5.3%
Financial Fact:
Income tax expense: 29M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.70, $0.04 better than the analyst estimate of $0.66. Revenue for the quarter came in at $4.56 billion versus the consensus estimate of $4.41 billion.
GUIDANCE:
Boston Scientific sees FY2025 EPS of $2.80-$2.87, versus the consensus of $2.81.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Electra Is Said to Guide IPO Pricing to Upper Half of Range
- Roundtable signs $1B, 10-year deal with Paradium.AI for media platform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
